阿尔尼拉姆制药公司将投资2.5亿美元,增加酶连接平台到美国制造设施,以应对全球对RNAi治疗日益增长的需求。
阿尔尼拉姆制药公司将投资2.5亿美元,增加酶连接平台到美国制造设施,以应对全球对RNAi治疗日益增长的需求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.